Suppr超能文献

心力衰竭伴射血分数保留和轻至中度继发性二尖瓣反流患者的运动时心功能、血液动力学和瓣膜功能。

Cardiac function, haemodynamics, and valve competence with exercise in patients with heart failure with preserved ejection fraction and mild to moderate secondary mitral regurgitation.

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Eur J Heart Fail. 2024 Jul;26(7):1616-1627. doi: 10.1002/ejhf.3322. Epub 2024 Jun 4.

Abstract

AIMS

This study aimed to evaluate the clinical significance of secondary mitral regurgitation (MR) in patients with heart failure with preserved ejection fraction (HFpEF).

METHODS AND RESULTS

We conducted a prospective study enrolling consecutively evaluated patients with HFpEF undergoing invasive haemodynamic exercise testing with simultaneous echocardiography. Compared to HFpEF without MR (n = 145, 79.7%), those with mild or moderate MR (n = 37, 20.3%) were older, more likely to be women, had more left ventricular (LV) systolic dysfunction, and more likely to have left atrial (LA) myopathy reflected by greater burden of atrial fibrillation, more LA dilatation, and poorer LA function. Pulmonary artery (PA) wedge pressure was higher at rest in HFpEF with MR (17 ± 5 mmHg vs. 20 ± 5 mmHg, p = 0.005), but there was no difference with exercise. At rest, only 2 (1.1%) patients had moderate MR, and none developed severe MR. Pulmonary vascular resistance was higher, and right ventricular (RV)-PA coupling was more impaired in patients with HFpEF and MR at rest and exercise. LV and LA myocardial dysfunction remained more severe in patients with MR during stress compared to those without MR, characterized by greater LA dilatation during all stages of exertion, lower LA emptying fraction and compliance, steeper and rightward-shifted LA pressure-volume relationships, and reduced LV longitudinal contractile function.

CONCLUSIONS

Patients with HFpEF and mild or moderate MR have more severe LV systolic dysfunction, LA myopathy, RV-PA uncoupling, and more severe pulmonary vascular disease. Mitral valve incompetence in this setting is a phenotypic marker of more advanced disease but is not a causal factor in development of HFpEF.

摘要

目的

本研究旨在评估射血分数保留的心力衰竭(HFpEF)患者中继发性二尖瓣反流(MR)的临床意义。

方法和结果

我们进行了一项前瞻性研究,纳入了连续评估的 HFpEF 患者,这些患者接受了侵入性血流动力学运动测试,并同时进行了超声心动图检查。与无 MR 的 HFpEF 患者(n=145,79.7%)相比,有轻度或中度 MR 的患者(n=37,20.3%)年龄更大,更可能为女性,左心室(LV)收缩功能障碍更严重,心房颤动的负担更大,左心房(LA)扩张更明显,LA 功能更差,提示 LA 肌病更常见。HFpEF 合并 MR 患者静息时肺动脉楔压更高(17±5mmHg 比 20±5mmHg,p=0.005),但运动时无差异。静息时,仅 2 例(1.1%)患者为中度 MR,无一例发展为重度 MR。静息时和运动时,HFpEF 合并 MR 患者的肺血管阻力更高,右心室(RV)-PA 偶联更受损。与无 MR 的患者相比,MR 患者在应激时 LV 和 LA 心肌功能障碍更严重,表现为在所有运动阶段 LA 扩张更大,LA 排空分数和顺应性更低,LA 压力-容积关系更陡峭且右移,以及 LV 纵向收缩功能降低。

结论

HFpEF 合并轻度或中度 MR 的患者左心室收缩功能障碍更严重,LA 肌病、RV-PA 失偶联和更严重的肺血管疾病更常见。二尖瓣关闭不全在此情况下是更晚期疾病的表型标志物,但不是 HFpEF 发展的因果因素。

相似文献

2
Identification of Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Symptomatic Atrial Fibrillation.
JACC Heart Fail. 2023 Nov;11(11):1626-1638. doi: 10.1016/j.jchf.2023.07.019. Epub 2023 Sep 6.
3
Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2020 Mar;22(3):489-498. doi: 10.1002/ejhf.1699. Epub 2020 Jan 7.
5
Chronotropic Incompetence and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2025 Jul;14(13):e037290. doi: 10.1161/JAHA.124.037290. Epub 2025 Jun 18.
6
Qualitative and quantitative assessment of atrial functional mitral regurgitation: analysis from the REVEAL-AFMR registry.
Eur Heart J Cardiovasc Imaging. 2025 Jan 31;26(2):299-306. doi: 10.1093/ehjci/jeae288.
7
Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy.
Cardiovasc Ultrasound. 2025 Feb 3;23(1):1. doi: 10.1186/s12947-024-00336-w.

本文引用的文献

1
Prevalence and prognostic impact of dynamic atrial functional mitral regurgitation assessed by isometric handgrip exercise.
Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):589-598. doi: 10.1093/ehjci/jead336.
2
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.
Nat Med. 2023 Sep;29(9):2358-2365. doi: 10.1038/s41591-023-02526-x. Epub 2023 Aug 27.
3
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
4
Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
J Am Coll Cardiol. 2023 May 9;81(18):1810-1834. doi: 10.1016/j.jacc.2023.01.049. Epub 2023 Apr 19.
5
Diagnostic value of reduced left atrial compliance during ergometry exercise in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Aug;25(8):1293-1303. doi: 10.1002/ejhf.2862. Epub 2023 Apr 26.
6
Right Ventricular Failure.
N Engl J Med. 2023 Mar 23;388(12):1111-1125. doi: 10.1056/NEJMra2207410.
7
Heart Failure With Preserved Ejection Fraction: A Review.
JAMA. 2023 Mar 14;329(10):827-838. doi: 10.1001/jama.2023.2020.
8
Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
JACC Heart Fail. 2023 Jun;11(6):646-658. doi: 10.1016/j.jchf.2023.01.008. Epub 2023 Mar 1.
10
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Eur Heart J. 2022 Sep 21;43(36):3417-3431. doi: 10.1093/eurheartj/ehac184.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验